The disclosed invention includes pharmaceutical compositions and methods for treating inflammatory conditions, particularly those that are characterized by increased binding of alpha-9 integrin to one or more of its ligands. Also disclosed are methods for selecting compounds for use in such compositions and methods.

 
Web www.patentalert.com

< Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells to chemotherapy

< Antibody fragment-peg conjugates

> Factor VIII polypeptide

> 3 agonists and uses thereof
~ 00205